Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vor Bio to Participate in Upcoming Investor Conferences By: Vor Biopharma via GlobeNewswire April 18, 2023 at 08:00 AM EDT CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual SummitFireside Chat: Monday, April 24, 2023 at 9:30 am ET H.C. Wainwright BioConnect Investor Conference Fireside Chat: Tuesday, May 2, 2023 at 12:00 pm ETLocation: Nasdaq World Headquarters, New York, NY The JMP Securities Life Sciences ConferenceFireside Chat: Tuesday, May 16, 2023 at 3:00 pm ETLocation: New York Hilton Midtown, New York, NY A live webcast and archived replay of the fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/ About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Investors & MediaSarah Spencer +1 857-242-6076sspencer@vorbio.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Vor Bio to Participate in Upcoming Investor Conferences By: Vor Biopharma via GlobeNewswire April 18, 2023 at 08:00 AM EDT CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual SummitFireside Chat: Monday, April 24, 2023 at 9:30 am ET H.C. Wainwright BioConnect Investor Conference Fireside Chat: Tuesday, May 2, 2023 at 12:00 pm ETLocation: Nasdaq World Headquarters, New York, NY The JMP Securities Life Sciences ConferenceFireside Chat: Tuesday, May 16, 2023 at 3:00 pm ETLocation: New York Hilton Midtown, New York, NY A live webcast and archived replay of the fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/ About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Investors & MediaSarah Spencer +1 857-242-6076sspencer@vorbio.com
CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual SummitFireside Chat: Monday, April 24, 2023 at 9:30 am ET H.C. Wainwright BioConnect Investor Conference Fireside Chat: Tuesday, May 2, 2023 at 12:00 pm ETLocation: Nasdaq World Headquarters, New York, NY The JMP Securities Life Sciences ConferenceFireside Chat: Tuesday, May 16, 2023 at 3:00 pm ETLocation: New York Hilton Midtown, New York, NY A live webcast and archived replay of the fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/ About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Investors & MediaSarah Spencer +1 857-242-6076sspencer@vorbio.com